ArticleSignal transduction and targeted therapy2026

Investigation of a clinical trial drug VV261 as a potent antiviral candidate against Chikungunya virus.

Yumin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.